Synaptotagmin XI in Parkinson's disease: New evidence from an association study in Spain and Mexico

[1]  Chuong B. Do,et al.  Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease , 2014, Nature Genetics.

[2]  Christopher R. Gignoux,et al.  The genetics of Mexico recapitulates Native American substructure and affects biomedical traits , 2014, Science.

[3]  S. Pappatà,et al.  PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family , 2014, neurogenetics.

[4]  K. Lunetta,et al.  Correction for multiple testing in a gene region , 2013, European Journal of Human Genetics.

[5]  E. Dietrichs,et al.  Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease , 2013, Neurobiology of Aging.

[6]  W. Sun,et al.  Developmental expression and subcellular distribution of synaptotagmin 11 in rat hippocampus , 2012, Neuroscience.

[7]  J. Ioannidis,et al.  A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants , 2012, Journal of Medical Genetics.

[8]  S. Sawcer,et al.  Systematic Review and UK‐Based Study of PARK2 (parkin), PINK1, PARK7 (DJ‐1) and LRRK2 in early‐onset Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[9]  J. Ioannidis,et al.  Large-scale replication and heterogeneity in Parkinson disease genetic loci , 2012, Neurology.

[10]  H. Morita,et al.  Exome sequencing reveals a homozygous SYT14 mutation in adult-onset, autosomal-recessive spinocerebellar ataxia with psychomotor retardation. , 2011, American journal of human genetics.

[11]  O. Combarros,et al.  Replication of MAPT and SNCA, but not PARK16‐18, as susceptibility genes for Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[12]  Mohamad Saad,et al.  Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies , 2011, The Lancet.

[13]  Sudarshan C. Upadhya,et al.  Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease. , 2011, Biochimica et biophysica acta.

[14]  A. Morris,et al.  Data quality control in genetic case-control association studies , 2010, Nature Protocols.

[15]  S. Limborska,et al.  Molecular mechanisms of pathogenesis of Parkinson's disease. , 2010, International review of cell and molecular biology.

[16]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[17]  P. Donnelly,et al.  A new multipoint method for genome-wide association studies by imputation of genotypes , 2007, Nature Genetics.

[18]  Eden R Martin,et al.  No gene is an island: the flip-flop phenomenon. , 2007, American journal of human genetics.

[19]  Mariza de Andrade,et al.  High-resolution whole-genome association study of Parkinson disease. , 2005, American journal of human genetics.

[20]  H. Zoghbi,et al.  The Effects of the Polyglutamine Repeat Protein Ataxin-1 on the UbL-UBA Protein A1Up* , 2004, Journal of Biological Chemistry.

[21]  C. Tyler-Smith,et al.  Micro-geographical differentiation in Northern Iberia revealed by Y-chromosomal DNA analysis. , 2004, Gene.

[22]  S. Pulst,et al.  Screening for mutations in synaptotagmin XI in Parkinson's disease. , 2004, Journal of neural transmission. Supplementum.

[23]  S. Gilman,et al.  Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.

[24]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.